ScienceInsider Interviews Two Ebola Survivors

ScienceInsider interviews two Ebola survivors about their experience with the virus.

ScienceInsider: Ebola survivor I, Senga Omeonga: ‘Every day I’m still thinking: When was I contaminated?’
“…[Senga Omeonga, a medical doctor from the Democratic Republic of Congo,] was one of a handful of people worldwide to receive ZMapp, an experimental antibody cocktail. … On 24 September, he spoke with Science about his experience, including his suspicions about how he became infected, and the epidemic now devastating Liberia, Guinea, and Sierra Leone…” (Cohen, 10/2).

ScienceInsider: Ebola survivor II, Nancy Writebol: ‘We just don’t even have a clue what happened’
“…[Nancy] Writebol, a clinical nurse associate, became ill with the disease while working for the missionary group SIM in Monrovia. She and her husband David spoke with Science on 24 September about a topic that has yet to receive much attention: How do health care workers who are trained to protect themselves nevertheless become infected with the Ebola virus? The Writebols also discuss how the outbreak grew into an epidemic, as well as the treatment she received both in Liberia and then at Emory University Hospital in Atlanta…” (Cohen, 10/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.